Draft guidance on management of rolling reviews for drug submissions: Overview

This guidance helps sponsors interpret amendments to the Food and Drug Regulations (regulations) that allow a sponsor to apply for rolling review status for a forthcoming drug submission that meets specific eligibility conditions.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2023-09-01

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data